fryhofer

AMA Update 429: CDC changes COVID isolation guidelines and COVID vaccine dose schedule with Sandra Fryhofer, MD

Our guest is Sandra Fryhofer, MD, AMA’s liaison to the Advisory Committee on Immunization Practices (ACIP) and a member of ACIP’s COVID-19 Vaccine Workgroup. American Medical Association CXO Todd Unger hosts.

🩺 The AMA is your powerful ally in patient care. Join now: https://bit.ly/AMAJoinRenew

Read More

AMA Update 245: ‘Kraken’ variant & vaccine stroke risk: everything you need to know with Sandra Fryhofer, MD

The latest on Pfizer’s COVID vaccine and stroke risk. Sandra Fryhofer, MD, breaks down vaccine safety statistics following new #FDA and #CDC announcements about possible increased risk of stroke after getting Pfizer’s bivalent booster shot. Also covering VSD, other #vaccine databases, and what’s expected at the Vaccines and Related Biological Products Advisory Committee (VBRPAC) meeting this January. Plus everything you need to know about the ‘Kraken’ — a.k.a, the XBB.1.5 #omicron variant. American Medical Association CXO Todd Unger hosts #AMAUpdate

Read More

AMA Update 199: Sandra Fryhofer, MD, on who needs a higher dose flu vaccine

Everything you need to know about the 2022-2023 flu season, including: types of flu vaccines available, when you should get vaccinated—as well as which shot you, adults over 65, and those with egg allergies should get. Sandra Fryhofer, MD, is AMA’s liaison to the Advisory Committee on Immunization Practices (ACIP), and a member of ACIP’s COVID-19 Vaccine Workgroup. American Medical Association CXO Todd Unger hosts.

Read More

AMA Update 109: Sandra Fryhofer, MD, discusses updated booster recs for teens and more

AMA CXO Todd Unger discusses news from the recent meeting of the CDC’s Advisory Committee on Immunization Practices, or ACIP, with Sandra Fryhofer, MD, AMA’s liaison to ACIP, and a member of ACIP’s COVID-19 Vaccine Workgroup. Updates include new COVID booster recommendations for teens, a shorter booster interval after a Pfizer vaccine series, new additional dose recommendations for immunocompromised children, and what you need to know about Pfizer’s new COVID vaccine formulation for adults. Also reviewing new data about preventing MIS-C (multisystem inflammatory syndrome) in children, as well as recent decision memos from the CDC director.

Read More

AMA Update 86: Dr. Sandra Fryhofer shares what physicians need to know about boosters

AMA CXO Todd Unger talks boosters with Dr. Sandra Fryhofer, AMA’s liaison to the Advisory Committee on Immunization Practices. Learn what physicians need to know about the latest Pfizer booster authorization, including who is eligible, why boosters are needed and what this means for our larger efforts to fight the pandemic. 

Read More

AMA Update 52: Vaccine and variant update with Dr. Sandra Fryhofer

A discussion with Dr. Sandra Fryhofer, the AMA’s liaison to the CDC’s Advisory Committee on Immunization Practices (ACIP), who takes a closer look at the delta variant and other variants of concern. She also covers what physicians need to know about authorized COVID vaccines, including real-world effectiveness and rare adverse events.

Read More